Radosa, Julia Caroline http://orcid.org/0000-0003-2024-2907
Radosa, Marc Philipp
Zimmermann, Julia Sarah Maria
Braun, Eva-Marie
Findeklee, Sebastian
Wieczorek, Annette
Stotz, Lisa
Hamza, Amr
Takacs, Ferenc Zoltan
Risius, Uda Mareke
Gerlinger, Christoph
Radosa, Christoph Georg
Wagenpfeil, Stefan
Solomayer, Erich-Franz
Funding for this research was provided by:
Universität des Saarlandes (HOMFOR 2041601)
Universität des Saarlandes
Article History
Received: 18 January 2021
Accepted: 9 April 2021
First Online: 3 May 2021
Declarations
:
: Dr. Julia Caroline Radosa, Dr. Christoph Gerlinger, Dr. Lisa Stotz, Professor Dr. Stefan Wagenpfeil and Professor Dr. Erich–Franz Solomayer declare no conflict of interest regarding the submitted work. Regarding interactions outside the submitted work, Dr. Julia Radosa has received travel grants from Medac GmbH (Wedel, Germany), Gedeon Richter (Budapest, Hungary), and Celgene (Summit, USA), Daiichi Sankyo (Tokyo, Japan), Pfizer (New York City, USA) and was an honorary speaker for Pfizer (New York City, USA) in the past. Dr. Lisa Stotz has received travel grants from Medac GmbH (Wedel, Germany) and Celgene (Summit, USA) outside the submitted work in the past. Dr. Christoph Gerlinger is a full-time employee of Bayer AG (Berlin, Germany). Professor Dr. Stefan Wagenpfeil is receiving grants from Saarland University (Saarbruecken, Germany) and Servier (Suresnes Cedex, France) outside the submitted work. Professor Dr. Erich–Franz Solomayer is receiving grants from the University of Saarland, Storz, and Erbe; personal fees and other compensation from Roche (Basel, Switzerland), Pfizer (New York City, USA), Celgene (Summit USA), Amgen (Thousand Oaks, USA), and Astra Zeneca (Cambridge, GB); other fees from Johnson & Johnson (New Brunswick, USA), Novartis (Basel, Switzerland), Tesaro (Waltham, USA), Medac GmbH (Wedel, Germany), MSD (Kenilworth, USA), Vifor (Sankt Gallen, Switzerland), Gedeon Richter (Budapest, Hungary), Takeda (Tokyo, Japan), and AGE (Buchholz, Germany) outside the submitted work. Dr. Marc Philipp Radosa, Dr. Eva-Marie Braun, Dr. Sebastian Findeklee, Dr. Annette Wieczorek, Dr. Julia Zimmermann, Dr. Amr Hamza, Dr. Ferenc Zoltan Takacs, Professor Dr. Uda Mareke Risius and Dr. Christoph Radosa declare no potential conflict of interest regarding the submitted work and outside the submitted work.
: This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Saarland Institutional Review Board (2nd November 2016/ Reference No. 85/16), the study was registered with the German Clinical Trials Register (DRKS) (No. DRKS00009904).